Skip to main content
NCBI home page
British Journal of Pharmacology logoLink to British Journal of Pharmacology
. 1995 Sep;116(2):1918–1922. doi: 10.1111/j.1476-5381.1995.tb16683.x

Enhanced sympathetic neurotransmission in the tail artery of 1,3-dipropyl-8-sulphophenylxanthine (DPSPX)-treated rats.

P Karoon 1, A Rubino 1, G Burnstock 1
PMCID: PMC1909084  PMID: 8528580

Abstract

1. Sympathetic neurotransmission and noradrenaline content of the tail artery of Wistar rats treated for 7 days with the adenosine antagonist, 1,3-dipropyl-8-sulphophenylxanthine (DPSPX), were examined. 2. Systolic blood pressure of the DPSPX-treated rats (164.0 +/- 2.9 mmHg; n = 6) was significantly greater than saline-treated controls (140.0 +/- 2.8 mmHg; n = 5) after 7 days treatment. 3. The pressor responses of the arterial rings to transmural nerve stimulation (65 V, 0.1 ms, 4-64 Hz, for 1 s) were markedly enhanced in the DPSPX-treated compared with the saline-treated animals. Both noradrenergic and purinergic components of perivascular sympathetic neurotransmission were enhanced during DPSPX-induced hypertension. 4. Vasoconstrictor responses to exogenous noradrenaline (0.1-300 microM) and adenosine 5'-triphosphate (0.01-3 mM) were unaffected after DPSPX treatment, indicating prejunctional alteration of sympathetic cotransmission during DPSPX-induced hypertension. 5. Acute exposure to DPSPX (10 microM) did not modify vasoconstrictor responses to transmural nerve stimulation, thus supporting the claim that the enhancement of sympathetic neurotransmission only results from long-term DPSPX treatment. 6. The noradrenaline content of the tail arteries of DPSPX-treated (4.498 +/- 0.26 ng cm-1; n = 4) was significantly greater than saline-treated (3.440 +/- 0.30 ng cm-1; n = 5) animals. 7. These findings show that chronic inhibition of the actions of endogenous adenosine by DPSPX results in an elevation of systolic blood pressure accompanied by enhanced sympathetic cotransmission and enhanced noradrenaline content of the rat tail artery.

Full text

PDF
1918

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Azevedo I., Osswald W. Does adenosine malfunction play a role in hypertension? Pharmacol Res. 1992 Apr;25(3):227–236. doi: 10.1016/s1043-6618(05)80071-4. [DOI] [PubMed] [Google Scholar]
  2. Bao J. X. Sympathetic neuromuscular transmission in rat tail artery: a study based on electrochemical, electrophysiological and mechanical recording. Acta Physiol Scand Suppl. 1993;610:1–58. [PubMed] [Google Scholar]
  3. Cassis L. A., Stitzel R. E., Head R. J. Hypernoradrenergic innervation of the caudal artery of the spontaneously hypertensive rat: an influence upon neuroeffector mechanisms. J Pharmacol Exp Ther. 1985 Sep;234(3):792–803. [PubMed] [Google Scholar]
  4. Cheung D. W. Vascular neuroeffector mechanisms in hypertension. Can J Physiol Pharmacol. 1989 Sep;67(9):1146–1150. doi: 10.1139/y89-182. [DOI] [PubMed] [Google Scholar]
  5. Dalziel H. H., Machaly M., Sneddon P. Comparison of the purinergic contribution to sympathetic vascular responses in SHR and WKY rats in vitro and in vivo. Eur J Pharmacol. 1989 Nov 28;173(1):19–26. doi: 10.1016/0014-2999(89)90004-6. [DOI] [PubMed] [Google Scholar]
  6. Donohue S. J., Stitzel R. E., Head R. J. Time course of changes in the norepinephrine content of tissues from spontaneously hypertensive and Wistar Kyoto rats. J Pharmacol Exp Ther. 1988 Apr;245(1):24–31. [PubMed] [Google Scholar]
  7. Evans R. J., Cunnane T. C. Relative contributions of ATP and noradrenaline to the nerve evoked contraction of the rabbit jejunal artery. Dependence on stimulation parameters. Naunyn Schmiedebergs Arch Pharmacol. 1992 Apr;345(4):424–430. doi: 10.1007/BF00176620. [DOI] [PubMed] [Google Scholar]
  8. Guild S. B., Jenkinson S., Muir T. C. The interaction between noradrenaline and ATP upon polyphosphoinositide metabolism and contraction in tail arteries from normo- and hypertensive rats. J Pharm Pharmacol. 1992 Oct;44(10):836–840. doi: 10.1111/j.2042-7158.1992.tb03215.x. [DOI] [PubMed] [Google Scholar]
  9. Head R. J., Cassis L. A., Robinson R. L., Westfall D. P., Stitzel R. E. Altered catecholamine contents in vascular and nonvascular tissues in genetically hypertensive rats. Blood Vessels. 1985;22(4):196–204. doi: 10.1159/000158601. [DOI] [PubMed] [Google Scholar]
  10. Head R. J. Hypernoradrenergic innervation: its relationship to functional and hyperplastic changes in the vasculature of the spontaneously hypertensive rat. Blood Vessels. 1989;26(1):1–20. [PubMed] [Google Scholar]
  11. Jackson E. K. Role of adenosine in noradrenergic neurotransmission in spontaneously hypertensive rats. Am J Physiol. 1987 Oct;253(4 Pt 2):H909–H918. doi: 10.1152/ajpheart.1987.253.4.H909. [DOI] [PubMed] [Google Scholar]
  12. Judy W. V., Watanabe A. M., Henry D. P., Besch H. R., Jr, Murphy W. R., Hockel G. M. Sympathetic nerve activity: role in regulation of blood pressure in the spontaenously hypertensive rat. Circ Res. 1976 Jun;38(6 Suppl 2):21–29. doi: 10.1161/01.res.38.6.21. [DOI] [PubMed] [Google Scholar]
  13. Kubo T., Su C. Effects of adenosine on [3H]norepinephrine release from perfused mesenteric arteries of SHR and renal hypertensive rats. Eur J Pharmacol. 1983 Feb 18;87(2-3):349–352. doi: 10.1016/0014-2999(83)90352-7. [DOI] [PubMed] [Google Scholar]
  14. Lundin S., Ricksten S. E., Thorén P. Renal sympathetic activity in spontaneously hypertensive rats and normotensive controls, as studied by three different methods. Acta Physiol Scand. 1984 Feb;120(2):265–272. doi: 10.1111/j.1748-1716.1984.tb00133.x. [DOI] [PubMed] [Google Scholar]
  15. Matias A., Albino-Teixeira A., Polónia J., Azevedo I. Long-term administration of 1,3-dipropyl-8-sulfophenylxanthine causes arterial hypertension. Eur J Pharmacol. 1991 Jan 25;193(1):101–104. doi: 10.1016/0014-2999(91)90206-6. [DOI] [PubMed] [Google Scholar]
  16. Medgett I. C., Hicks P. E., Langer S. Z. Smooth muscle alpha-2 adrenoceptors mediate vasoconstrictor responses to exogenous norepinephrine and to sympathetic stimulation to a greater extent in spontaneously hypertensive than in Wistar Kyoto rat tail arteries. J Pharmacol Exp Ther. 1984 Oct;231(1):159–165. [PubMed] [Google Scholar]
  17. Muir T. C., Wardle K. A. Vascular smooth muscle responses in normo- and hypertensive rats to sympathetic nerve stimulation and putative transmitters. J Auton Pharmacol. 1989 Feb;9(1):23–34. doi: 10.1111/j.1474-8673.1989.tb00193.x. [DOI] [PubMed] [Google Scholar]
  18. Olsson R. A., Pearson J. D. Cardiovascular purinoceptors. Physiol Rev. 1990 Jul;70(3):761–845. doi: 10.1152/physrev.1990.70.3.761. [DOI] [PubMed] [Google Scholar]
  19. Owens G. K., Rabinovitch P. S., Schwartz S. M. Smooth muscle cell hypertrophy versus hyperplasia in hypertension. Proc Natl Acad Sci U S A. 1981 Dec;78(12):7759–7763. doi: 10.1073/pnas.78.12.7759. [DOI] [PMC free article] [PubMed] [Google Scholar]
  20. Persson M. G., Ohlén A., Lindbom L., Hedqvist P., Gustafsson L. E. Role of adenosine in functional hyperemia in skeletal muscle as indicated by pharmacological tools. Naunyn Schmiedebergs Arch Pharmacol. 1991 Jan;343(1):52–57. doi: 10.1007/BF00180676. [DOI] [PubMed] [Google Scholar]
  21. Scott T. M., Pang S. C. The correlation between the development of sympathetic innervation and the development of medial hypertrophy in jejunal arteries in normotensive and spontaneously hypertensive rats. J Auton Nerv Syst. 1983 May;8(1):25–32. doi: 10.1016/0165-1838(83)90020-6. [DOI] [PubMed] [Google Scholar]
  22. Sneddon P., Burnstock G. ATP as a co-transmitter in rat tail artery. Eur J Pharmacol. 1984 Oct 30;106(1):149–152. doi: 10.1016/0014-2999(84)90688-5. [DOI] [PubMed] [Google Scholar]
  23. Vidal M., Hicks P. E., Langer S. Z. Differential effects of alpha-beta-methylene ATP on responses to nerve stimulation in SHR and WKY tail arteries. Naunyn Schmiedebergs Arch Pharmacol. 1986 Apr;332(4):384–390. doi: 10.1007/BF00500092. [DOI] [PubMed] [Google Scholar]
  24. Westfall T. C., Meldrum M. J. Alterations in the release of norepinephrine at the vascular neuroeffector junction in hypertension. Annu Rev Pharmacol Toxicol. 1985;25:621–641. doi: 10.1146/annurev.pa.25.040185.003201. [DOI] [PubMed] [Google Scholar]

Articles from British Journal of Pharmacology are provided here courtesy of The British Pharmacological Society

RESOURCES